STOCK TITAN

Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW) announced its CFO, Raphi Levy, will present at the Jefferies Radiopharma Innovation Summit on April 3, 2023, from 3:30-4:00 PM ET in New York City. This summit focuses on innovations in the radiopharmaceutical sector. Levy will also conduct one-on-one investor meetings during the event. Founded in 2016, Alpha Tau specializes in the development of the Alpha DaRT™, a novel alpha-radiation therapy aimed at treating solid tumors. The technology was initially developed by experts from Tel Aviv University.

Positive
  • None.
Negative
  • None.

JERUSALEM, March 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chief Financial Officer, will present in-person at the Jefferies Radiopharma Innovation Summit in New York City on Monday, April 3rd, 2023.

Event:Jefferies Radiopharma Innovation Summit
Date:Monday, April 3rd, 2023
Time:3:30-4:00 PM ET
Location:Jefferies, NY, New York

Raphi Levy will also be available for 1x1 investor meetings at the conference. Please reach out to your Jefferies representative to schedule.

About Alpha Tau Medical, Ltd.

Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

Investor Relations Contact:
IR@alphatau.com


FAQ

What is the date and time of Alpha Tau's presentation at the Jefferies Summit?

Alpha Tau's presentation is on April 3, 2023, from 3:30-4:00 PM ET.

Who will represent Alpha Tau at the Jefferies Radiopharma Innovation Summit?

Raphi Levy, the CFO of Alpha Tau, will represent the company.

Where is the Jefferies Radiopharma Innovation Summit taking place?

The summit is located in New York City.

What is the main focus of Alpha Tau Medical Ltd.?

Alpha Tau focuses on developing the Alpha DaRT™, a novel cancer therapy for treating solid tumors.

How can investors meet with Alpha Tau's CFO during the Jefferies Summit?

Investors can schedule one-on-one meetings with Raphi Levy by contacting their Jefferies representative.

Alpha Tau Medical Ltd. Ordinary Shares

NASDAQ:DRTS

DRTS Rankings

DRTS Latest News

DRTS Stock Data

220.82M
52.18M
25.56%
1.94%
0.1%
Biotechnology
Healthcare
Link
United States of America
Jerusalem